Newswire

Published October 21, 2026

Ensysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, Dubai

Read the full story at Newswire

Ensysce Biosciences is a clinical-stage biotechnology company developing novel neuroplastogenic therapies using psychedelics that go beyond mood.